Benperidol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Hydrocodone | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Magnesium sulfate | The therapeutic efficacy of Benperidol can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Benperidol may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Mirtazapine | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Orphenadrine | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Rotigotine | Benperidol may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Benperidol. |
| Sodium oxybate | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Thalidomide | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Benperidol may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Benperidol is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Benperidol is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Benperidol. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Benperidol. |
| Sulpiride | Benperidol may increase the antipsychotic activities of Sulpiride. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Benperidol. |
| Lithium citrate | Lithium citrate may increase the neurotoxic activities of Benperidol. |
| Lithium hydroxide | Lithium hydroxide may increase the neurotoxic activities of Benperidol. |
| Mequitazine | Benperidol may increase the arrhythmogenic activities of Mequitazine. |
| Ethanol | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Benperidol may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Benperidol. |
| Zimelidine | The risk or severity of adverse effects can be increased when Benperidol is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Benperidol is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Benperidol is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Benperidol is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Benperidol is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Benperidol is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Benperidol is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Benperidol is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Benperidol is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Benperidol is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Benperidol is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Benperidol is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Benperidol is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Benperidol is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Benperidol. |
| Indalpine | The risk or severity of adverse effects can be increased when Benperidol is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Benperidol is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Benperidol is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Benperidol. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Benperidol. |
| Zopiclone | The risk or severity of adverse effects can be increased when Benperidol is combined with Zopiclone. |
| Eletriptan | The risk or severity of adverse effects can be increased when Eletriptan is combined with Benperidol. |
| Cabergoline | The risk or severity of adverse effects can be increased when Cabergoline is combined with Benperidol. |
| Zolmitriptan | The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Benperidol. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Benperidol. |
| Dextromethorphan | The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Benperidol. |
| Mazindol | The risk or severity of adverse effects can be increased when Mazindol is combined with Benperidol. |
| Linezolid | The risk or severity of adverse effects can be increased when Linezolid is combined with Benperidol. |
| Sumatriptan | The risk or severity of adverse effects can be increased when Sumatriptan is combined with Benperidol. |
| Ergotamine | The risk or severity of adverse effects can be increased when Ergotamine is combined with Benperidol. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Benperidol. |
| Almotriptan | The risk or severity of adverse effects can be increased when Almotriptan is combined with Benperidol. |
| Naratriptan | The risk or severity of adverse effects can be increased when Naratriptan is combined with Benperidol. |
| Rizatriptan | The risk or severity of adverse effects can be increased when Rizatriptan is combined with Benperidol. |
| Frovatriptan | The risk or severity of adverse effects can be increased when Frovatriptan is combined with Benperidol. |
| Chlorpheniramine | The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Benperidol. |
| Procarbazine | The risk or severity of adverse effects can be increased when Procarbazine is combined with Benperidol. |
| Bromocriptine | The risk or severity of adverse effects can be increased when Bromocriptine is combined with Benperidol. |
| Ergometrine | The risk or severity of adverse effects can be increased when Ergometrine is combined with Benperidol. |
| Rasagiline | The risk or severity of adverse effects can be increased when Rasagiline is combined with Benperidol. |
| Lorcaserin | The risk or severity of adverse effects can be increased when Lorcaserin is combined with Benperidol. |
| Etoperidone | The risk or severity of adverse effects can be increased when Etoperidone is combined with Benperidol. |
| Lorpiprazole | The risk or severity of adverse effects can be increased when Lorpiprazole is combined with Benperidol. |
| Amphetamine | Benperidol may decrease the stimulatory activities of Amphetamine. |
| Phentermine | Benperidol may decrease the stimulatory activities of Phentermine. |
| Pseudoephedrine | Benperidol may decrease the stimulatory activities of Pseudoephedrine. |
| Benzphetamine | Benperidol may decrease the stimulatory activities of Benzphetamine. |
| Diethylpropion | Benperidol may decrease the stimulatory activities of Diethylpropion. |
| Lisdexamfetamine | Benperidol may decrease the stimulatory activities of Lisdexamfetamine. |
| Mephentermine | Benperidol may decrease the stimulatory activities of Mephentermine. |
| MMDA | Benperidol may decrease the stimulatory activities of MMDA. |
| 2,5-Dimethoxy-4-ethylamphetamine | Benperidol may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylamphetamine. |
| Chlorphentermine | Benperidol may decrease the stimulatory activities of Chlorphentermine. |
| Methylenedioxyethamphetamine | Benperidol may decrease the stimulatory activities of Methylenedioxyethamphetamine. |
| Dextroamphetamine | Benperidol may decrease the stimulatory activities of Dextroamphetamine. |
| Metamfetamine | Benperidol may decrease the stimulatory activities of Metamfetamine. |
| Iofetamine I-123 | Benperidol may decrease the stimulatory activities of Iofetamine I-123. |
| Ritobegron | Benperidol may decrease the stimulatory activities of Ritobegron. |
| Mephedrone | Benperidol may decrease the stimulatory activities of Mephedrone. |
| Methoxyphenamine | Benperidol may decrease the stimulatory activities of Methoxyphenamine. |
| Gepefrine | Benperidol may decrease the stimulatory activities of Gepefrine. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | Benperidol may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylthioamphetamine. |
| Phendimetrazine | Benperidol may decrease the stimulatory activities of Phendimetrazine. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Benperidol. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Benperidol. |